Our patrons and trustees
Baroness Morgan of Drefelin (Patron)
Breast Cancer Now Chief Executive since April 2015, Delyth Morgan previously enjoyed a varied voluntary sector career, which included ten years as Breakthrough Breast Cancer Chief Executive and Chief Executive of Breast Cancer Campaign in 2011. In 2014, Delyth played a pivotal role in the merger of Breast Cancer Campaign and Breakthrough Breast Cancer. Occupying a number of Government ministerial posts from 2007, she now sits as an independent peer in the House of Lords.
Delyth said: “I have seen first hand how devastating a diagnosis can be and I am convinced there must be more that can be done to improve survival and quality of life for people with pancreatic cancer.”
Eleanor Phillips (Chair)
Eleanor’s career in Human Resources, includes roles as Chief HR Officer for global, UK listed companies. Her appointment as Trustee, achieves a long-held ambition to support the Charity, following the loss of her mother to pancreatic cancer in 2013.
Eleanor said: “We had no experience of pancreatic cancer as a family, so the prognosis was very difficult to understand and accept. How is it possible that survival rates have barely improved in 50 years? Also, we had the complexity of finding specialist help in West Wales. Knowledge and resources were limited, and we received invaluable support from the nurses at Pancreatic Cancer UK.
“As well as helping the Charity through my own lived experiences, I will bring my background in developing skilled and characterful organisations with a shared passion and purpose. Those with pancreatic cancer deserve far better odds. I am proud to be part of a team committed to making this happen.”
Anne Tutt (Treasurer)
Anne is a qualified Chartered Accountant, FCA, with more than 25 years of Board level experience. She has extensive experience of the private, public, charitable and social enterprise sectors, and has worked in many business sectors, including banking, manufacturing, automotive, business services and healthcare, for UK and multinational groups.
Anne has a portfolio of independent non-executive roles and specialises in corporate governance, audit committees, risk management and financial strategy. Her current portfolio includes Vice Chair of Oxford University Hospitals NHS Trust & Council Member at Swansea University.
Anne said: “I lost my husband to pancreatic cancer, also a close business colleague. I am so happy to be joining the Board of Pancreatic Cancer UK, giving me the opportunity to make a contribution to fighting this dreadful disease and supporting those people and their families who are suffering from it.”
Greg Mueller (Trustee)
Greg is an experienced corporate and commercial lawyer, having lived and worked in Canada, Singapore, China and the UK over the course of his career. He is currently the Deputy General Counsel of AstraZeneca, based in Cambridge. During his time at AZ, he also served as a Non-Executive Director for its Bombay and National Stock Exchange listed business in India. Greg holds a Bachelor of Commerce specialist degree (B.Comm) from the University of Toronto and a law degree (LLB) from Queen’s University in Canada.
Greg said: “My father died recently from pancreatic cancer and from the time of his diagnosis, I was struck by the poor prognosis and relative lack of treatment options for most patients as well as the heavy toll the disease takes on family, friends and caregivers. As a result, I feel very personally connected to the fight against pancreatic cancer. I believe that with my experience, I make a meaningful contribution and that by working with the team at Pancreatic Cancer UK, we can make a real difference.”
Katie Stotter (Trustee)
Katie is a Strategy Consultant who has spent the last 13 years working with some of the world’s biggest healthcare, entertainment, and telco brands, along with charities, universities and Governments, to make new products and services, embrace change, innovate and get creative.
Katie said: “I lost my dad to Pancreatic Cancer when he was in his early 50s. Not long after, my granny also died from it. The speed of disease progression, and the impact on our family was enormous. So many years later, I was shocked to find that survival rates have improved so little. I am determined to use the skills and experience that I have to drive real change and better outcomes, so that fewer families have to face such a challenging period and devastating loss as we did.”
Neil Balmer (Trustee)
Neil has worked in healthcare strategy, communications and campaigning for 20 years, with charities, the NHS, medical bodies, businesses and in politics. He’s currently working with the South London and Maudsley NHS Trust to develop a South London wide mental health prevention and recovery programme.
Before that he was Director of Strategy and Engagement at MQ, the UK’s leading mental health research charity – having helped to launch and establish the charity, as member of its founding Executive team.
Neil said: “Pancreatic cancer is cause very close to my heart. 26 years ago, my mother died from pancreatic neuroendocrine cancer, aged just 49. I’m honoured and excited to be working with Pancreatic Cancer UK to help drive forward much-needed progress for every person affected by this devastating condition and their families.”
Rima Horton (Trustee)
“My late husband, Alan Rickman died in January 2016. By the time his cancer was discovered, it was inoperable. So, I am very keen on understanding any developments that might lead to better screening and earlier diagnosis.
“Following a degree in Physiology and Biochemistry and a research position, I changed careers and taught economics at two universities in applied microeconomics with particular focus on public sector economics. A great love is politics and I served as a councillor for the Royal Borough of Kensington and Chelsea, St Charles ward in North Kensington for twenty years. I have served on a number of public sector Boards and I since 1988 I have been the Chair of Governors for Barlby Primary School, a North Kensington community school. Another passion is the arts – especially theatre and film.”
Jeremy Hand (Trustee)
Jeremy Hand has built a successful career supporting leadership teams and growing exceptional businesses. As well as founding and growing several of his own companies, he brings huge experience at the intersect of strategy, successful execution and impact.
Jeremy said: “5 years ago, I was diagnosed with pancreatic cancer. Today, I am completely clear and proud to be joining the board of trustees at Pancreatic Cancer UK to help tackle this most fatal of all cancers.”
Rachel Backshall (Trustee)
“My career and experience in sales and marketing spans around 40 years starting with 15 years in the retail sector and after the achievement of an MBA I moved to work with BT for around 6 years. I then made a conscious decision to move to the not-for-profit sector and use my skills to generate much-needed income for charitable causes.
“With now over 20 years of charitable fundraising experience with organisations such as Marie Curie, Parkinson’s UK and currently working as Director of Fundraising and Communications for Whizz Kidz, I am keen to support the work of another organisation from a trustee perspective. I am keen to bring my expertise and passion for driving positive change within Pancreatic Cancer UK, helping to guide and support the organisation to achieve its mission. I have always been drawn to medical charities and when I joined Marie Curie Cancer Care it was my first step into the unknown world of cancer. I can now look back and say it was a step I am glad I took as it opened my eyes to the needs of those with the condition and the need to find treatments and a cure to give hope to all.
“My personal brush with Pancreatic cancer came a couple of years ago when they found 2 cysts on my pancreas – thankfully these are currently not giving me any issues.”
Pete Wilson (Trustee)
Pete has worked in private equity for approximately 20 years, partnering with management teams to support their businesses to grow. He has significant board experience as a non-executive board member of companies across a range of sectors, including healthcare, B2B services, manufacturing, travel, and retail.
Prior to this, he worked in strategy consulting, with a particular focus on media and telecommunications companies, including BT and the BBC.
Pete said: “Having lost my Dad to pancreatic cancer, I have first-hand experience of the brutality of this disease and am determined to support PCUK in improving outcomes for others impacted by it.”
Nick Lemoine (Trustee)
Nick is a clinician scientist who worked in pancreatic cancer research for more than thirty years, focused on understanding the molecular genetics of the disease and developing novel biological therapies.
He is currently Professor of Molecular Oncology at Barts Cancer Institute, Queen Mary University of London, and also National Director of Strategic Development in the NIHR Research Delivery Network.
He has served as Chair of Trustee Boards for the Medical Research Foundation, Global Alliance for Chronic Diseases, and the Africa Research Excellence Fund, as well as chairing scientific advisory boards and funding committees for several charities including Pancreatic Cancer UK.
Nick said: “I am immensely grateful to Pancreatic Cancer UK for supporting research across the country into early detection and transforming treatment for this dreadful disease over many years. I am very proud now to serve as a Trustee and help guide strategy to achieve the Charity’s exciting and ambitious aims for the future.”
Geraint Lewis (Trustee)
Geraint is a public health physician with a focus on data and technology, who is currently serving as the Director of Population Health at Microsoft for Europe, the Middle East, and Africa.
His previous roles include Chief Data Officer at NHS England, and Senior Director of Outcomes and Analytics at Walgreens. A fellow of the Royal College of Physicians of London, Geraint’s academic interests include predictive risk modelling and preventive health. Geraint’s experience in technology, healthcare strategy, and public health will all help support Pancreatic Cancer UK to achieve its mission.
Geraint recently lost a close colleague to pancreatic cancer, which has deepened his commitment to the cause.
Geraint said: “The loss of my colleague underlined for me the urgent need for better detection, treatment options, and support for those affected by pancreatic cancer. I am honoured to join Pancreatic Cancer UK as a Trustee.”
Latest news
4 February 2025
Our response to the new National Cancer Plan consultation
Secretary of State for Health and Social Care, Wes Streeting has announced the launch of the consultation for the new Cancer Plan.
15 January 2025
Support with the rising cost of living
Find out how to get the support you need to deal with the rising cost of living, from benefits and grants to tips for eating well on a budget.
10 January 2025
Four esteemed new trustees bolster our board
We are delighted to announce that four new trustees have joined our Board of Trustees.